Donhexocin



Compound IDCDAMM01262
Common nameDonhexocin
IUPAC name4-(2,8,13,14,17,18-hexahydroxytriacontyl)-2-methyl-2H-furan-5-one
Molecular formulaC35H66O8

Experimental data

Retention time23.38
Adduct[M+H]+
Actual mz615.484
Theoretical mz615.483
Error0.53
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5659

Identifiers and class information

Inchi keyIRCFRVYGUCFTPA-UHFFFAOYNA-N
SmilesO=C1OC(C=C1CC(O)CCCCCC(O)CCCCC(O)C(O)CCC(O)C(O)CCCCCCCCCCCC)C
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)35
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)614.902
Computed dipole moment(dipole)9.677
Total solvent accessible surface area (SASA)1272.69
Hydrophobic component of SASA (FOSA)985.902
Hydrophilic component of SASA (FISA)254.762
Pie component of the SASA (PISA)32.031
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2289.19
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)13.2
Free energy of solvation of dipole (dip^2/V)0.0409073
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0254054
Globularity descriptor (glob)0.660027
Predicted polarizability in cubic angstroms (QPpolrz)63.292
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.953
Predicted octanol/gas partition coefficient (QPlogPoct)36.324
Predicted water/gas partition coefficient (QPlogPw)18.802
Predicted octanol/water partition coefficient (QPlogPo/w)5.403
Predicted aqueous solubility (QPlogS)-7.855
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.298
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.186
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)38.018
Predicted brain/blood partition coefficient (QPlogBB)-5.445
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)14.438
Predicted skin permeability, log Kp (QPlogKp)-2.742
PM3 calculated ionization potential (IP(ev))10.527
PM3 calculated electron affinity (EA(eV))0.438
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.239
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)47.986
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)159.791
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1

Copyright © 2025